Core Insights - The health consumption sector is undergoing significant generational changes, with a rapid increase in immediate, personalized, and scenario-based health demands, transforming instant retail into a new infrastructure for the pharmaceutical and health industry [1] - The instant retail market is projected to exceed 2 trillion yuan by 2030, with the O2O pharmaceutical sector expected to be a major growth driver [1] Group 1: Business Growth and Strategies - JD's "Buy Medicine in Seconds" service has seen over 100% year-on-year growth in partnered stores and a 200% increase in order volume, with a network covering 490 cities [1] - The service's full-chain solution, including platform policies, traffic support, and growth strategies, has become a key engine for driving business growth for partner merchants [2] - During the 618 shopping festival, order volume for "Buy Medicine in Seconds" surged over 400% year-on-year, with new user numbers increasing by over 600% [2] Group 2: Merchant Support and Incentives - A merchant evaluation system has been introduced to help stores quickly identify operational weaknesses, with over 100 merchants participating in the incentive program in 2025 [3] - The platform provides various support measures for new merchants, including dedicated service guidance, advertising subsidies, and traffic support [3] Group 3: Brand Value and Market Positioning - JD's service is helping pharmaceutical companies transition from merely selling products to delivering health value, supported by a nationwide supply network and rapid delivery capabilities [4] - The platform's insights into consumer behavior and category trends assist pharmaceutical companies in optimizing product strategies [4] Group 4: Marketing and Consumer Engagement - JD has launched targeted marketing campaigns, such as the "Warm Winter Delivery" initiative, which significantly increased GMV and new customer acquisition [5] - The marketing efforts focus on addressing user pain points and enhancing brand trust through meaningful engagement [5] Group 5: Future Developments and Innovations - The pharmaceutical O2O market is entering a critical phase of "value co-creation," with JD planning to leverage its digital capabilities to empower partners further [6][7] - The "京医千询" medical model and AI-driven tools are set to enhance intelligent product selection and precise marketing for merchants [7] - Future policies will include reduced shipping costs and incentives for high-growth merchants, aiming to lower operational costs and enhance growth certainty [7]